Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

被引：429

作者：

Lip, Gregory Y. H. ^{[1
]}

Windecker, Stephan ^{[1
]}

Huber, Kurt ^{[1
]}

Kirchhof, Paulus ^{[1
]}

Marin, Francisco ^{[1
]}

Ten Berg, Jurrien M. ^{[1
]}

Haeusler, Karl Georg ^{[1
]}

Boriani, Giuseppe ^{[1
]}

Capodanno, Davide ^{[1
]}

Gilard, Martine ^{[1
]}

Zeymer, Uwe ^{[1
]}

Lane, Deirdre ^{[1
]}

机构：

[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England

来源：

EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 45期

关键词：

DUAL ANTIPLATELET THERAPY; ORAL ANTICOAGULATION THERAPY; PERI-PROCEDURAL ANTICOAGULATION; ACUTE MYOCARDIAL-INFARCTION; VITAMIN-K ANTAGONISTS; DRUG-ELUTING STENTS; 2012 FOCUSED UPDATE; ESC GUIDELINES; CATHETER ABLATION; TRIPLE THERAPY;

D O I：

10.1093/eurheartj/ehu298

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3155 / 3179

页数：25

共 142 条

[1] Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation [J].

Ahmed, Imdad ;

Gertner, Elie ;

Nelson, William B. ;

House, Chad M. ;

Dahiya, Ranjan ;

Anderson, Christopher P. ;

Benditt, David G. ;

Zhu, Dennis W. X. .

HEART RHYTHM, 2010, 7 (06) :745-749

[2] Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial [J].

Alexander, John H. ;

Lopes, Renato D. ;

Thomas, Laine ;

Alings, Marco ;

Atar, Dan ;

Aylward, Philip ;

Goto, Shinya ;

Hanna, Michael ;

Huber, Kurt ;

Husted, Steen ;

Lewis, Basil S. ;

McMurray, John J. V. ;

Pais, Prem ;

Pouleur, Hubert ;

Steg, Philippe Gabriel ;

Verheugt, Freek W. A. ;

Wojdyla, Daniel M. ;

Granger, Christopher B. ;

Wallentin, Lars .

EUROPEAN HEART JOURNAL, 2014, 35 (04) :224-232

[3] Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome [J].

Alexander, John H. ;

Lopes, Renato D. ;

James, Stefan ;

Kilaru, Rakhi ;

He, Yaohua ;

Mohan, Puneet ;

Bhatt, Deepak L. ;

Goodman, Shaun ;

Verheugt, Freek W. ;

Flather, Marcus ;

Huber, Kurt ;

Liaw, Danny ;

Husted, Steen E. ;

Lopez-Sendon, Jose ;

De Caterina, Raffaele ;

Jansky, Petr ;

Darius, Harald ;

Vinereanu, Dragos ;

Cornel, Jan H. ;

Cools, Frank ;

Atar, Dan ;

Luis Leiva-Pons, Jose ;

Keltai, Matyas ;

Ogawa, Hisao ;

Pais, Prem ;

Parkhomenko, Alexander ;

Ruzyllo, Witold ;

Diaz, Rafael ;

White, Harvey ;

Ruda, Mikhail ;

Geraldes, Margarida ;

Lawrence, Jack ;

Harrington, Robert A. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) :699-708

[4] Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].

Alexander, John H. ;

Becker, Richard C. ;

Bhatt, Deepak L. ;

Cools, Frank ;

Crea, Filippo ;

Dellborg, Mikael ;

Fox, Keith A. A. ;

Goodman, Shaun G. ;

Harrington, Robert A. ;

Huber, Kurt ;

Husted, Steen ;

Lewis, Basil S. ;

Lopez-Sendon, Jose ;

Mohan, Puneet ;

Montalescot, Gilles ;

Ruda, Mikhail ;

Ruzyllo, Witold ;

Verheugt, Freek ;

Wallentin, Lars ;

Darius, Harald ;

Simoons, Maarten ;

Boersma, Eric ;

DeLemos, James ;

Spencer, Fred .

CIRCULATION, 2009, 119 (22) :2877-U39

[5] Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT2R2 Score [J].

Apostolakis, Stavros ;

Sullivan, Renee M. ;

Olshansky, Brian ;

Lip, Gregory Y. H. .

CHEST, 2013, 144 (05) :1555-1563

[6] Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease Report of the Guideline Development Subcommittee of the American Academy of Neurology [J].

Armstrong, Melissa J. ;

Gronseth, Gary ;

Anderson, David C. ;

Biller, Jose ;

Cucchiara, Brett ;

Dafer, Rima ;

Goldstein, Larry B. ;

Schneck, Michael ;

Messe, Steven R. .

NEUROLOGY, 2013, 80 (22) :2065-2069

[7] The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation [J].

Azoulay, Laurent ;

Dell'Aniello, Sophie ;

Simon, Teresa ;

Renoux, Christel ;

Suissa, Samy .

THROMBOSIS AND HAEMOSTASIS, 2013, 109 (03) :431-439

[8] New-Onset Atrial Fibrillation is Associated With Cardiovascular Events Leading to Death in a First Time Myocardial Infarction Population of 89 703 Patients With Long-Term Follow-Up: A Nationwide Study [J].

Bang, Casper N. ;

Gislason, Gunnar H. ;

Greve, Anders M. ;

Bang, Christian A. ;

Lilja, Alexander ;

Torp-Pedersen, Christian ;

Andersen, Per K. ;

Kober, Lars ;

Devereux, Richard B. ;

Wachtell, Kristian .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (01) :e000382

[9] Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation [J].

Bernard, Anne ;

Fauchier, Laurent ;

Pellegrin, Celine ;

Clementy, Nicolas ;

Saint Etienne, Christophe ;

Banerjee, Amitava ;

Naudin, Djedjiga ;

Angoulvant, Denis .

THROMBOSIS AND HAEMOSTASIS, 2013, 110 (03) :560-568

[10] Low molecular weight heparin bridging for atrial fibrillation: is VTE thromboprophylaxis the major benefit? [J].

Billett, Henny H. ;

Scorziello, Barbara A. ;

Giannattasio, Emily R. ;

Cohen, Hillel W. .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 30 (04) :479-485

← 1 2 3 4 5 6 7 8 9 10 →